$9.29
-0.15-1.59%
$9.29
-0.15-1.59%
Korro Bio (KRRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.33 | $-1.91 | $-2.05 | $-2.65 |
| Actual | $-1.07 | $-1.69 | $-5.32 | $-1.92 |
| Surprise | +19.6% | +11.5% | -159.5% | +27.6% |
| Revenue | ||||
| Estimate | $433336 | $650512 | $855000 | $846936 |
| Actual | $0 | $0 | $1.3M | $1.1M |
| Surprise | -100.0% | -100.0% | +50.9% | +28.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.24 | $-1.35 | $-1.06 | $-1.09 |
| Revenue | ||||
| Consensus | $450000 | $450000 | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.07 | $-1.33 | 19.6 % |
| Q1 | May 7, 2026 | $-1.69 | $-1.91 | 11.5 % |
| Q4 | Mar 12, 2026 | $-5.32 | $-2.05 | -159.5 % |
| Q3 | Nov 12, 2025 | $-1.92 | $-2.65 | 27.6 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $433.34K | -100.0 % |
| Q1 | May 7, 2026 | $0 | $650.51K | -100.0 % |
| Q4 | Mar 12, 2026 | $1.29M | $855.00K | 50.9 % |
| Q3 | Nov 12, 2025 | $1.09M | $846.94K | 28.7 % |